0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
TCR Based Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-13O13689
Home | Market Reports | Health| Nursing
Global TCR Based Therapy Market Research Report 2023
BUY CHAPTERS

TCR Based Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13O13689
Report
October 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

TCR Based Therapy - Market Size

The global market for TCR Based Therapy was estimated to be worth US$ 45 million in 2023 and is forecast to a readjusted size of US$ 63 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

TCR Based Therapy - Market

TCR Based Therapy - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for TCR Based Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of TCR Based Therapy by region & country, by Type, and by Application.
The TCR Based Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR Based Therapy.
Market Segmentation

Scope of TCR Based Therapy - Market Report

Report Metric Details
Report Name TCR Based Therapy - Market
Forecasted market size in 2030 US$ 63 million
CAGR 4.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Transduction of Chimeric Antigen Receptor
  • Transduction of TCR α/β Heterodimer
Segment by Application
  • Hospitals
  • Clinics & Ambulatory Centers
  • Cancer Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Adaptimmune Therapeutics, Alaunos Therapeutics, Bristol Myers Squibb, Cellular Biomedicine, Gilead Biosciences, GlaxoSmithKline, Immatics, Immunocore, Lion TCR, Takara Bio, Zelluna Immunotherapy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of TCR Based Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of TCR Based Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of TCR Based Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the TCR Based Therapy - Market size in 2030?

Ans: The TCR Based Therapy - Market size in 2030 will be US$ 63 million.

Who are the main players in the TCR Based Therapy - Market report?

Ans: The main players in the TCR Based Therapy - Market are Adaptimmune Therapeutics, Alaunos Therapeutics, Bristol Myers Squibb, Cellular Biomedicine, Gilead Biosciences, GlaxoSmithKline, Immatics, Immunocore, Lion TCR, Takara Bio, Zelluna Immunotherapy

What are the Application segmentation covered in the TCR Based Therapy - Market report?

Ans: The Applications covered in the TCR Based Therapy - Market report are Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes, Others

What are the Type segmentation covered in the TCR Based Therapy - Market report?

Ans: The Types covered in the TCR Based Therapy - Market report are Transduction of Chimeric Antigen Receptor, Transduction of TCR α/β Heterodimer

1 Market Overview
1.1 TCR Based Therapy Product Introduction
1.2 Global TCR Based Therapy Market Size Forecast
1.3 TCR Based Therapy Market Trends & Drivers
1.3.1 TCR Based Therapy Industry Trends
1.3.2 TCR Based Therapy Market Drivers & Opportunity
1.3.3 TCR Based Therapy Market Challenges
1.3.4 TCR Based Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global TCR Based Therapy Players Revenue Ranking (2023)
2.2 Global TCR Based Therapy Revenue by Company (2019-2024)
2.3 Key Companies TCR Based Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies TCR Based Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of TCR Based Therapy
2.6 TCR Based Therapy Market Competitive Analysis
2.6.1 TCR Based Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by TCR Based Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Transduction of Chimeric Antigen Receptor
3.1.2 Transduction of TCR α/β Heterodimer
3.2 Global TCR Based Therapy Sales Value by Type
3.2.1 Global TCR Based Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global TCR Based Therapy Sales Value, by Type (2019-2030)
3.2.3 Global TCR Based Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics & Ambulatory Centers
4.1.3 Cancer Research Institutes
4.1.4 Others
4.2 Global TCR Based Therapy Sales Value by Application
4.2.1 Global TCR Based Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global TCR Based Therapy Sales Value, by Application (2019-2030)
4.2.3 Global TCR Based Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global TCR Based Therapy Sales Value by Region
5.1.1 Global TCR Based Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global TCR Based Therapy Sales Value by Region (2019-2024)
5.1.3 Global TCR Based Therapy Sales Value by Region (2025-2030)
5.1.4 Global TCR Based Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America TCR Based Therapy Sales Value, 2019-2030
5.2.2 North America TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe TCR Based Therapy Sales Value, 2019-2030
5.3.2 Europe TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific TCR Based Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America TCR Based Therapy Sales Value, 2019-2030
5.5.2 South America TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa TCR Based Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions TCR Based Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions TCR Based Therapy Sales Value
6.3 United States
6.3.1 United States TCR Based Therapy Sales Value, 2019-2030
6.3.2 United States TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States TCR Based Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe TCR Based Therapy Sales Value, 2019-2030
6.4.2 Europe TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe TCR Based Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China TCR Based Therapy Sales Value, 2019-2030
6.5.2 China TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China TCR Based Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan TCR Based Therapy Sales Value, 2019-2030
6.6.2 Japan TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan TCR Based Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea TCR Based Therapy Sales Value, 2019-2030
6.7.2 South Korea TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea TCR Based Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia TCR Based Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia TCR Based Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India TCR Based Therapy Sales Value, 2019-2030
6.9.2 India TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India TCR Based Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Adaptimmune Therapeutics
7.1.1 Adaptimmune Therapeutics Profile
7.1.2 Adaptimmune Therapeutics Main Business
7.1.3 Adaptimmune Therapeutics TCR Based Therapy Products, Services and Solutions
7.1.4 Adaptimmune Therapeutics TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Adaptimmune Therapeutics Recent Developments
7.2 Alaunos Therapeutics
7.2.1 Alaunos Therapeutics Profile
7.2.2 Alaunos Therapeutics Main Business
7.2.3 Alaunos Therapeutics TCR Based Therapy Products, Services and Solutions
7.2.4 Alaunos Therapeutics TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Alaunos Therapeutics Recent Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Profile
7.3.2 Bristol Myers Squibb Main Business
7.3.3 Bristol Myers Squibb TCR Based Therapy Products, Services and Solutions
7.3.4 Bristol Myers Squibb TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Cellular Biomedicine Recent Developments
7.4 Cellular Biomedicine
7.4.1 Cellular Biomedicine Profile
7.4.2 Cellular Biomedicine Main Business
7.4.3 Cellular Biomedicine TCR Based Therapy Products, Services and Solutions
7.4.4 Cellular Biomedicine TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Cellular Biomedicine Recent Developments
7.5 Gilead Biosciences
7.5.1 Gilead Biosciences Profile
7.5.2 Gilead Biosciences Main Business
7.5.3 Gilead Biosciences TCR Based Therapy Products, Services and Solutions
7.5.4 Gilead Biosciences TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Gilead Biosciences Recent Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Profile
7.6.2 GlaxoSmithKline Main Business
7.6.3 GlaxoSmithKline TCR Based Therapy Products, Services and Solutions
7.6.4 GlaxoSmithKline TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 GlaxoSmithKline Recent Developments
7.7 Immatics
7.7.1 Immatics Profile
7.7.2 Immatics Main Business
7.7.3 Immatics TCR Based Therapy Products, Services and Solutions
7.7.4 Immatics TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Immatics Recent Developments
7.8 Immunocore
7.8.1 Immunocore Profile
7.8.2 Immunocore Main Business
7.8.3 Immunocore TCR Based Therapy Products, Services and Solutions
7.8.4 Immunocore TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Immunocore Recent Developments
7.9 Lion TCR
7.9.1 Lion TCR Profile
7.9.2 Lion TCR Main Business
7.9.3 Lion TCR TCR Based Therapy Products, Services and Solutions
7.9.4 Lion TCR TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Lion TCR Recent Developments
7.10 Takara Bio
7.10.1 Takara Bio Profile
7.10.2 Takara Bio Main Business
7.10.3 Takara Bio TCR Based Therapy Products, Services and Solutions
7.10.4 Takara Bio TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Takara Bio Recent Developments
7.11 Zelluna Immunotherapy
7.11.1 Zelluna Immunotherapy Profile
7.11.2 Zelluna Immunotherapy Main Business
7.11.3 Zelluna Immunotherapy TCR Based Therapy Products, Services and Solutions
7.11.4 Zelluna Immunotherapy TCR Based Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Zelluna Immunotherapy Recent Developments
8 Industry Chain Analysis
8.1 TCR Based Therapy Industrial Chain
8.2 TCR Based Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 TCR Based Therapy Sales Model
8.5.2 Sales Channel
8.5.3 TCR Based Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. TCR Based Therapy Market Trends
    Table 2. TCR Based Therapy Market Drivers & Opportunity
    Table 3. TCR Based Therapy Market Challenges
    Table 4. TCR Based Therapy Market Restraints
    Table 5. Global TCR Based Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global TCR Based Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies TCR Based Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies TCR Based Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of TCR Based Therapy
    Table 10. Global TCR Based Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global TCR Based Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global TCR Based Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global TCR Based Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global TCR Based Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global TCR Based Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global TCR Based Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global TCR Based Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global TCR Based Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global TCR Based Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global TCR Based Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global TCR Based Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global TCR Based Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global TCR Based Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global TCR Based Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global TCR Based Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions TCR Based Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions TCR Based Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions TCR Based Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Adaptimmune Therapeutics Basic Information List
    Table 32. Adaptimmune Therapeutics Description and Business Overview
    Table 33. Adaptimmune Therapeutics TCR Based Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in TCR Based Therapy Business of Adaptimmune Therapeutics (2019-2024)
    Table 35. Adaptimmune Therapeutics Recent Developments
    Table 36. Alaunos Therapeutics Basic Information List
    Table 37. Alaunos Therapeutics Description and Business Overview
    Table 38. Alaunos Therapeutics TCR Based Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in TCR Based Therapy Business of Alaunos Therapeutics (2019-2024)
    Table 40. Alaunos Therapeutics Recent Developments
    Table 41. Bristol Myers Squibb Basic Information List
    Table 42. Bristol Myers Squibb Description and Business Overview
    Table 43. Bristol Myers Squibb TCR Based Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in TCR Based Therapy Business of Bristol Myers Squibb (2019-2024)
    Table 45. Bristol Myers Squibb Recent Developments
    Table 46. Cellular Biomedicine Basic Information List
    Table 47. Cellular Biomedicine Description and Business Overview
    Table 48. Cellular Biomedicine TCR Based Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in TCR Based Therapy Business of Cellular Biomedicine (2019-2024)
    Table 50. Cellular Biomedicine Recent Developments
    Table 51. Gilead Biosciences Basic Information List
    Table 52. Gilead Biosciences Description and Business Overview
    Table 53. Gilead Biosciences TCR Based Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in TCR Based Therapy Business of Gilead Biosciences (2019-2024)
    Table 55. Gilead Biosciences Recent Developments
    Table 56. GlaxoSmithKline Basic Information List
    Table 57. GlaxoSmithKline Description and Business Overview
    Table 58. GlaxoSmithKline TCR Based Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in TCR Based Therapy Business of GlaxoSmithKline (2019-2024)
    Table 60. GlaxoSmithKline Recent Developments
    Table 61. Immatics Basic Information List
    Table 62. Immatics Description and Business Overview
    Table 63. Immatics TCR Based Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in TCR Based Therapy Business of Immatics (2019-2024)
    Table 65. Immatics Recent Developments
    Table 66. Immunocore Basic Information List
    Table 67. Immunocore Description and Business Overview
    Table 68. Immunocore TCR Based Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in TCR Based Therapy Business of Immunocore (2019-2024)
    Table 70. Immunocore Recent Developments
    Table 71. Lion TCR Basic Information List
    Table 72. Lion TCR Description and Business Overview
    Table 73. Lion TCR TCR Based Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in TCR Based Therapy Business of Lion TCR (2019-2024)
    Table 75. Lion TCR Recent Developments
    Table 76. Takara Bio Basic Information List
    Table 77. Takara Bio Description and Business Overview
    Table 78. Takara Bio TCR Based Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in TCR Based Therapy Business of Takara Bio (2019-2024)
    Table 80. Takara Bio Recent Developments
    Table 81. Zelluna Immunotherapy Basic Information List
    Table 82. Zelluna Immunotherapy Description and Business Overview
    Table 83. Zelluna Immunotherapy TCR Based Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in TCR Based Therapy Business of Zelluna Immunotherapy (2019-2024)
    Table 85. Zelluna Immunotherapy Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. TCR Based Therapy Downstream Customers
    Table 89. TCR Based Therapy Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. TCR Based Therapy Product Picture
    Figure 2. Global TCR Based Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global TCR Based Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. TCR Based Therapy Report Years Considered
    Figure 5. Global TCR Based Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by TCR Based Therapy Revenue in 2023
    Figure 7. TCR Based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Transduction of Chimeric Antigen Receptor Picture
    Figure 9. Transduction of TCR α/β Heterodimer Picture
    Figure 10. Global TCR Based Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global TCR Based Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Clinics & Ambulatory Centers
    Figure 14. Product Picture of Cancer Research Institutes
    Figure 15. Product Picture of Others
    Figure 16. Global TCR Based Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global TCR Based Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America TCR Based Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe TCR Based Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific TCR Based Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America TCR Based Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa TCR Based Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa TCR Based Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions TCR Based Therapy Sales Value (%), (2019-2030)
    Figure 29. United States TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 35. China TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 37. China TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 47. India TCR Based Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India TCR Based Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 49. India TCR Based Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 50. TCR Based Therapy Industrial Chain
    Figure 51. TCR Based Therapy Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

IoT Smart Healthcare - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9W14014
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Treating Localized Stretch Marks - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14S14078
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Cryopreserved Animal Hepatocytes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39Y14310
Thu Oct 17 00:00:00 UTC 2024

Add to Cart